Valuation: Crossject

Market Cap 7.13Cr 8.03Cr 6.66Cr 6.07Cr 11Cr 771.67Cr 12Cr 81Cr 31Cr 394.49Cr 30Cr 29Cr 1.27TCr P/E 2026 *
3.2x
P/E 2027 * 2.52x
Enterprise Value 5.34Cr 6.01Cr 4.99Cr 4.54Cr 8.57Cr 578Cr 8.65Cr 60Cr 23Cr 295.48Cr 23Cr 22Cr 948.31Cr EV / Sales 2026 *
0.88x
EV / Sales 2027 * 0.37x
Free-Float
92.46%
Yield 2026 *
-
Yield 2027 * -
1 week-2.25%
Current month-4.69%
1 month-6.06%
3 months-26.36%
6 months-35.86%
Current year-39.16%
1 week 1.26
Extreme 1.262
1.39
1 month 1.26
Extreme 1.26
1.44
3 years 0.68
Extreme 0.677028625
5.7
5 years 0.68
Extreme 0.677028625
5.7
Manager TitleAgeSince
Chief Executive Officer 63 08/08/2001
Director of Finance/CFO - 25/03/2026
Corporate Officer/Principal - 20/08/2024
Director TitleAgeSince
Chairman 67 26/06/2009
Director/Board Member 67 -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-2.98%-2.25%-34.04%-65.37% 8.03Cr
+0.84%-3.74%-27.56%+1.79% 17TCr
-0.07%-2.55%-11.59%+12.86% 11TCr
+0.90%+1.13%-25.66%+3.60% 11TCr
-1.24%-0.76%-49.50%-12.08% 7.39TCr
-0.24%+0.69%+2.08%+71.44% 5.9TCr
-0.86%+2.96%+12.91%+61.58% 5.13TCr
-0.71%-3.82%-8.68%-31.71% 4.82TCr
+0.12%-0.17%-17.87%+21.91% 4.08TCr
-1.01%-1.45%+27.31%-6.14% 3.22TCr
Average -0.25%-0.86%-13.26%+5.79% 7.67TCr
Weighted average by Cap. +0.03%-1.30%-17.07%+11.22%

Financials

2026 *2027 *
Net sales 6.08Cr 6.84Cr 5.67Cr 5.17Cr 9.75Cr 657.84Cr 9.85Cr 69Cr 27Cr 336.29Cr 26Cr 25Cr 1.08TCr 6.52Cr 7.34Cr 6.09Cr 5.55Cr 10Cr 705.44Cr 11Cr 74Cr 29Cr 360.63Cr 28Cr 27Cr 1.16TCr
Net income 2.83Cr 3.19Cr 2.64Cr 2.41Cr 4.54Cr 306.2Cr 4.58Cr 32Cr 12Cr 156.53Cr 12Cr 12Cr 502.37Cr 3.56Cr 4.01Cr 3.32Cr 3.03Cr 5.71Cr 385.18Cr 5.76Cr 40Cr 16Cr 196.91Cr 15Cr 15Cr 631.95Cr
Net Debt -1.79Cr -2.01Cr -1.67Cr -1.52Cr -2.87Cr -193.67Cr -2.9Cr -20Cr -7.83Cr -99Cr -7.56Cr -7.4Cr -317.75Cr -4.7Cr -5.29Cr -4.39Cr -4Cr -7.54Cr -508.52Cr -7.61Cr -53Cr -21Cr -259.96Cr -20Cr -19Cr -834.32Cr
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
-
Date Price Change
02/26/02 €1.302 -2.98%
01/26/01 €1.342 -1.76%
30/26/30 €1.366 +2.09%
29/26/29 €1.338 +4.86%
28/26/28 €1.276 -4.20%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.310EUR
Average target price
4.400EUR
Spread / Average Target
+235.88%

Annual profits - Rate of surprise